📰 John Botson News
John Botson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Botson. Real-time updates on events, politics, business and more.
November 30, 2023
Common themes included preferring a standard list of symptoms, active training programs, and the desire for community.
November 26, 2023
John Botson, MD, discusses his study examining real-world pegloticase plus immunomodulation co-therapy using data from an insurance claims database.
June 1, 2023
Brian LaMoreaux, MD, discusses data from an analysis of the MIRROR trial examining the impact of pegloticase plus methotrexate on patient-reported outcomes and quality of life measures among patients with uncontrolled gout.
April 13, 2023
An analysis of eGFR changes based on methotrexate use in the MIRROR trial offers new insight into the effects of pegloticase on renal function.
November 13, 2022
More support for add-on methotrexate to maintain protein drug's efficacy
July 12, 2022
Pegloticase plus methotrexate has been approved as a treatment for refractory gout.
May 24, 2022
-- Oral presentation on KRYSTEXXA (pegloticase injection) plus methotrexate to be held June 2, 2022 at 11:35 a.m. CEST-- -- Additional data presentations provide new insights on psychosocial and